Literature DB >> 22134844

Cognitive dysfunction and antiphospholipid antibodies.

Simone Appenzeller1, Aline Tamires Lapa, Jozélio Freire de Carvalho, Fernando Augusto Peres, Yehuda Shoenfeld.   

Abstract

Antiphospholipid syndrome (APS) is a multisystem prothrombotic condition, however, in recent years, its inflammatory nature has been studied extensively. Cerebral involvement is commonly observed in APS and results in different clinical manifestations. However, most of the studies include secondary APS. In this article, we review the prevalence, clinical characteristics, and physiopathology of cognitive impairment in patients with primary APS.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22134844     DOI： 10.1007/s11926-011-0224-4

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN： 1523-3774            Impact factor:   4.592


  19 in total

1.  Neuropsychological deficits associated with antiphospholipid antibodies.

Authors:  M W Jacobson; L J Rapport; P A Keenan; R D Coleman; G E Tietjen
Journal:  J Clin Exp Neuropsychol       Date:  1999-04       Impact factor: 2.475

2.  Prevalence and clinical features of dementia associated with the antiphospholipid syndrome and circulating anticoagulants.

Authors:  Joab Chapman; Mahmoud Abu-Katash; Rivka Inzelberg; Israel Yust; Miriam Y Neufeld; Nurith Vardinon; Therese A Treves; Amos D Korczyn
Journal:  J Neurol Sci       Date:  2002-11-15       Impact factor: 3.181

Review 3.  Antiphospholipid syndrome and cognition.

Authors:  Bernardo Liberato; Roger A Levy
Journal:  Clin Rev Allergy Immunol       Date:  2007-04       Impact factor: 8.667

4.  Quantifying subclinical central nervous lesions in primary antiphospholipid syndrome: the role of magnetization transfer imaging.

Authors:  Danieli Castro Oliveira de Andrade; Eduardo Ferreira Borba; Eloísa Bonfá; Jozélio Freire de Carvalho; Antônio José da Rocha; Antônio Carlos Maia
Journal:  J Magn Reson Imaging       Date:  2008-03       Impact factor: 4.813

Review 5.  The spectrum of neurologic disease associated with antiphospholipid antibodies. Lupus anticoagulants and anticardiolipin antibodies.

Authors:  S R Levine; K M Welch
Journal:  Arch Neurol       Date:  1987-08

6.  Recurrent stroke and multi-infarct dementia in systemic lupus erythematosus: association with antiphospholipid antibodies.

Authors:  R A Asherson; D Mercey; G Phillips; N Sheehan; A E Gharavi; E N Harris; G R Hughes
Journal:  Ann Rheum Dis       Date:  1987-08       Impact factor: 19.103

7.  Cognitive deficits in patients with antiphospholipid syndrome: association with clinical, laboratory, and brain magnetic resonance imaging findings.

Authors:  Maria G Tektonidou; Natassa Varsou; Grigorios Kotoulas; Anna Antoniou; Haralampos M Moutsopoulos
Journal:  Arch Intern Med       Date:  2006-11-13

Review 8.  Antiphospholipid syndrome.

Authors:  Guillermo Ruiz-Irastorza; Mark Crowther; Ware Branch; Munther A Khamashta
Journal:  Lancet       Date:  2010-09-06       Impact factor: 79.321

9.  The pathogenesis of neural injury in animal models of the antiphospholipid syndrome.

Authors:  Aviva Katzav; Yehuda Shoenfeld; Joab Chapman
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

10.  Anticardiolipin antibodies in normal subjects. Neuropsychological correlates and MRI findings.

Authors:  R Schmidt; P Auer-Grumbach; F Fazekas; H Offenbacher; P Kapeller
Journal:  Stroke       Date:  1995-05       Impact factor: 7.914
View more
  6 in total

Review 1.  Difficult clinical situations in the antiphospholipid syndrome.

Authors:  Renata Ferreira Rosa; Michelle Remião Ugolini-Lopes; Audrey Krüse Zeinad-Valim; Elbio D'Amico; Danieli Andrade
Journal:  Curr Rheumatol Rep       Date:  2015-04       Impact factor: 4.592

Review 2.  Non-stroke Central Neurologic Manifestations in Antiphospholipid Syndrome.

Authors:  Cécile M Yelnik; Elizabeth Kozora; Simone Appenzeller
Journal:  Curr Rheumatol Rep       Date:  2016-02       Impact factor: 4.592

Review 3.  Cognitive Dysfunction in Systemic Lupus Erythematosus: Immunopathology, Clinical Manifestations, Neuroimaging and Management.

Authors:  Dominic Seet; Nur Azizah Allameen; Jiacai Cho; Anselm Mak; Sen Hee Tay
Journal:  Rheumatol Ther       Date:  2021-05-15

4.  Presence of Anticardiolipin Antibodies in Patients with Dementia: A Systematic Review and Meta-Analysis.

Authors:  Md Asiful Islam; Fahmida Alam; Mohammad Amjad Kamal; Siew Hua Gan; Teguh Haryo Sasongko; Kah Keng Wong
Journal:  Front Aging Neurosci       Date:  2017-08-02       Impact factor: 5.750

Review 5.  Cognitive Impairment in Anti-Phospholipid Syndrome and Anti-Phospholipid Antibody Carriers.

Authors:  Fadi Hassan; Mohammad E Naffaa; Amir Saab; Chaim Putterman
Journal:  Brain Sci       Date:  2022-02-05

6.  Cognitive dysfunction improves in systemic lupus erythematosus: Results of a 10 years prospective study.

Authors:  Fulvia Ceccarelli; Carlo Perricone; Carmelo Pirone; Laura Massaro; Cristiano Alessandri; Concetta Mina; Massimo Marianetti; Francesca Romana Spinelli; Guido Valesini; Fabrizio Conti
Journal:  PLoS One       Date:  2018-05-03       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.